Gennex Laboratories Ltd - GENNEX LAB. Share Price

Sector: Pharmaceuticals | ISIN: INE509C01026

Trade

Gennex Laboratories Ltd Corporate Actions

20 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

12 Apr , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

07 Feb , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

07 Feb , 2023

12:00 AM

Results

View Details

04 Nov , 2022

12:00 AM

Results

View Details

04 Nov , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

06 Sep , 2022

12:00 AM

AGM

Announcement date: 06 Sep , 2022

View Details

19 Sep , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

30 Aug , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

01 Aug , 2022

12:00 AM

Results

View Details

01 Aug , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

18 Jul , 2022

12:00 AM

Rights

View Details

13 Jul , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

21 Jun , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

06 Sep , 2022

12:00 AM

BookCloser

View Details

Gennex Laboratories Ltd News and Update

Aditya Birla Group to invest Rs 1,250 crore into its financial services subsidiary

1 day ago |
5:44 PM

According to Aditya Birla Capital Ltd., the preferential issuance would take place at a cost of Rs 165.1 per equity share and is pending approval from shareholders.

Centre to Sell 3% Stake in Coal India Ltd, Aims to Raise ₹4,158 Crore

IIFL News Service |
01 June, 2023 |
5:43 PM

Q4FY23 Review: IEX Ltd: Confident of volume recovery

IIFL News Service |
29 May, 2023 |
5:39 PM

Lupin sets new laboratory in Vijayawada

IIFL News Service |
25 May, 2023 |
5:32 PM

Gennex Laboratories Ltd FINANCIALS

Select Period:

Particulars ( Rupees In Crores.)	--	--	--	--
Gross Sales	--	--	--	--
Excise Duty	--	--	--	--
Net Sales	--	--	--	--
Other Operating Income	--	--	--	--
Other Income	--	--	--	--
Total Income	--	--	--	--
Total Expenditure **	--	--	--	--
PBIDT	--	--	--	--
Interest	--	--	--	--
PBDT	--	--	--	--
Depreciation	--	--	--	--
Minority Interest Before NP	--	--	--	--
Tax	--	--	--	--
Deferred Tax	--	--	--	--
Reported Profit After Tax	--	--	--	--
Minority Interest After NP	--	--	--	--
Net Profit after Minority Interest	--	--	--	--
Extra-ordinary Items	--	--	--	--
Adjusted Profit After Extra-ordinary item	--	--	--	--
EPS (Unit Curr.)	--	--	--	--
Book Value (Unit Curr.)	--	--	--	--
Dividend (%)	--	--	--	--
Equity	--	--	--	--
Public Shareholding (Number)	--	--	--	--
Public Shareholding (%)	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--
PBIDTM(%)	--	--	--	--
PBDTM(%)	--	--	--	--
PATM(%)	--	--	--	--

No Record Found

Particulars ( Rupees In Crores.)	--	--	--	--
Gross Sales	--	--	--	--
Excise Duty	--	--	--	--
Net Sales	--	--	--	--
Other Operating Income	--	--	--	--
Other Income	--	--	--	--
Total Income	--	--	--	--
Total Expenditure **	--	--	--	--
PBIDT	--	--	--	--
Interest	--	--	--	--
PBDT	--	--	--	--
Depreciation	--	--	--	--
Minority Interest Before NP	--	--	--	--
Tax	--	--	--	--
Deferred Tax	--	--	--	--
Reported Profit After Tax	--	--	--	--
Minority Interest After NP	--	--	--	--
Net Profit after Minority Interest	--	--	--	--
Extra-ordinary Items	--	--	--	--
Adjusted Profit After Extra-ordinary item	--	--	--	--
EPS (Unit Curr.)	--	--	--	--
Book Value (Unit Curr.)	--	--	--	--
Dividend (%)	--	--	--	--
Equity	--	--	--	--
Public Shareholding (Number)	--	--	--	--
Public Shareholding (%)	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--
PBIDTM(%)	--	--	--	--
PBDTM(%)	--	--	--	--
PATM(%)	--	--	--	--

No Record Found

Gennex Laboratories Ltd PEER COMPARISON

Company Name	LTP (₹)	P/E (%)	Mkt.Cap (₹Cr.)	NP Qtr (₹Cr.)	Div.Yield (%)	Sales Qtr (₹.Cr)	Book Value (₹)
Sun Pharmaceuticals Industries Ltd	999.35	52.38	2,39,777.54	-1,020.82	1.15	5,800.85	98.98
Divis Laboratories Ltd	3,539.90	51.62	93,340.08	318.79	0.85	1,908.17	478.60
Cipla Ltd	966.85	29.96	77,910.84	355.49	0.88	3,485.68	305.25
Dr Reddys Laboratories Ltd	4,609.05	29.38	76,753.62	672.40	0.87	4,537.80	1,229.47
Torrent Pharmaceuticals Ltd	1,774.00	57.17	60,134.99	219.00	1.24	1,882.00	190.76

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Gennex Laboratories Ltd

Y Ravinder Reddy
Independent Director

Arihant Baid
Chairman & Managing Director

T M GopalaKrishnan
Whole-time Director

Sadhana Bhansali
Independent Director

A S Nageswar Rao
Independent Director

A Ranga Rao Pantulu
Independent Director

Summary

Summary Info Not Found

Reports by Gennex Laboratories Ltd
Annual ReportAuditors Report
Management DiscussionDirectors Report

Reports by Gennex Laboratories Ltd
Investor PresentationConference Call TranscriptConference Call Audio

Gennex Laboratories Ltd - GENNEX LAB. Share Price

Gennex Laboratories Ltd KEY RATIOS

Gennex Laboratories Ltd Corporate Actions

Gennex Laboratories Ltd SHAREHOLDING SNAPSHOT
03 June , 2023 | 11:48 PM

Knowledge Center

Gennex Laboratories Ltd News and Update

Aditya Birla Group to invest Rs 1,250 crore into its financial services subsidiary

Centre to Sell 3% Stake in Coal India Ltd, Aims to Raise ₹4,158 Crore

Q4FY23 Review: IEX Ltd: Confident of volume recovery

Lupin sets new laboratory in Vijayawada

Gennex Laboratories Ltd FINANCIALS

Select Period:

Gennex Laboratories Ltd QUICK LINKS

Quarterly Result

Half Yearly Result

Nine Monthly Result

Annual Result

Gennex Laboratories Ltd PEER COMPARISON

MORE ABOUT Gennex Laboratories Ltd

Summary

IIFL Customer Care Number

1860-267-3000 /7039-050-000

IIFL Securities Support Whatsapp Number

+91-9892691696

Download The App Now

IIFL Customer Care Number

1860-267-3000 /7039-050-000

IIFL Securities Support Whatsapp Number

+91-9892691696

Download The App Now

MARKET

IDEAS

MUTUAL FUNDS

TRADING DOCUMENTATION

CALCULATOR

GLOSSARY (A-Z)

Gennex Laboratories Ltd - GENNEX LAB. Share Price

Gennex Laboratories Ltd KEY RATIOS

Gennex Laboratories Ltd Corporate Actions

Gennex Laboratories Ltd SHAREHOLDING SNAPSHOT 03 June , 2023 | 11:48 PM

Knowledge Center

Gennex Laboratories Ltd News and Update

Gennex Laboratories Ltd FINANCIALS

Select Period:

Gennex Laboratories Ltd QUICK LINKS

Quarterly Result

Half Yearly Result

Nine Monthly Result

Annual Result

Gennex Laboratories Ltd PEER COMPARISON

MORE ABOUT Gennex Laboratories Ltd

Summary

IIFL Customer Care Number

IIFL Securities Support Whatsapp Number

Download The App Now

IIFL Customer Care Number

IIFL Securities Support Whatsapp Number

Download The App Now

Gennex Laboratories Ltd SHAREHOLDING SNAPSHOT
03 June , 2023 | 11:48 PM